Published in BMJ on February 28, 1998
Viagra: on release. Evidence on the effectiveness of sildenafil is good. BMJ (1998) 1.25
Evaluation of the aphrodisiac activity of Tribulus terrestris Linn. in sexually sluggish male albino rats. J Pharmacol Pharmacother (2012) 1.11
Erectile dysfunction among diabetic patients in saudi arabia: a hospital-based primary care study. J Family Community Med (2007) 0.81
The effect of DA-8159 on corpus cavernosal smooth muscle relaxation and penile erection in diabetic rabbits. Urol Res (2004) 0.76
Trials have shown yohimbine is effective for erectile dysfunction. BMJ (1998) 0.75
The hypoactive corpora cavernosa with degenerative erectile dysfunction: a new syndrome. BMC Urol (2006) 0.75
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol (1994) 10.03
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res (1996) 3.85
Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol (1996) 3.31
Physiology of penile erection. Physiol Rev (1995) 2.57
Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun (1990) 2.55
Impotence. N Engl J Med (1989) 2.12
Impotence and diabetes mellitus. J Am Med Assoc (1958) 1.98
Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med (1997) 1.37
Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol (1993) 1.28
Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet (1987) 1.26
Role of nitric oxide in the physiology of erection. Biol Reprod (1995) 1.17
Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue. Am J Physiol (1988) 1.15
Impotence: diagnosis and management of male erectile dysfunction. BMJ (1994) 1.05
The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection. Urol Clin North Am (1995) 0.93
Sexual dysfunction during antidepressant treatment. J Clin Psychiatry (1993) 0.91
The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction. J Urol (1994) 0.88
Pharmacosexology update: prescription drugs and sexual function. J Psychoactive Drugs (1986) 0.84
Recovery of erectile function by the oral administration of apomorphine. Urology (1995) 0.83
Visually stimulated erection in castrated men. J Urol (1995) 0.81
Erectile dysfunction. Endocrinol Metab Clin North Am (1994) 0.81
Clinical evaluation of impotence. Ann Acad Med Singapore (1995) 0.80
Sexual dysfunction in the diabetic patient with hypertension. Am J Cardiol (1988) 0.80
Clinical review 71: Advances in the understanding and management of erectile dysfunction. J Clin Endocrinol Metab (1995) 0.79
Erectile dysfunction. Are you prepared to discuss it? Postgrad Med (1995) 0.79
Diagnosis and treatment of vasculogenic impotence. Acta Chir Hung (1994) 0.79
Assessment and treatment of impotence. Med Clin North Am (1995) 0.79
Impotence. N Engl J Med (1989) 2.12
A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest (1991) 1.49
Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol (2001) 1.39
Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J Urol (1996) 1.24
PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol (1995) 1.09
In vivo assessment of trabecular smooth muscle tone, its application in pharmaco-cavernosometry and analysis of intracavernous pressure determinants. J Urol (1995) 1.09
Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol (1992) 1.06
Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part II--Clinical implications of penile buckling. Int J Impot Res (1998) 0.99
Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury. Eur J Med Res (1997) 0.96
Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest (1993) 0.96
Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol (1991) 0.96
Altered contractility of rabbit penile corpus cavernosum smooth muscle by hypoxia. J Urol (1996) 0.96
Possible role of Na(+)-K(+)-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide. Br J Pharmacol (1995) 0.92
Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol (1998) 0.91
Arterial priapism: diagnosis, treatment and long-term followup. J Urol (1994) 0.90
Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol (1992) 0.89
Clozapine-associated priapism: a case report. J Urol (1992) 0.87
Traumatic laceration of intracavernosal arteries: the pathophysiology of nonischemic, high flow, arterial priapism. J Urol (1990) 0.87
Prostanoid production in rabbit corpus cavernosum. II. Inhibition by oxidative stress. J Urol (1996) 0.86
A heterogeneous population of alpha 1 adrenergic receptors mediates contraction of human corpus cavernosum smooth muscle to norepinephrine. J Urol (1995) 0.85
Recurrent prolonged erections and priapism as a sequela of priapism: pathophysiology and management. J Urol (1991) 0.84
Characterization of muscarinic acetylcholine receptors in human penile corpus cavernosum: studies on whole tissue and cultured endothelium. J Urol (1990) 0.83
Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part III--Clinical considerations of penile hemodynamic and rigidity erectile responses. Int J Impot Res (1998) 0.82
Cholinergic neurotransmission in human corpus cavernosum. II. Acetylcholine synthesis. Am J Physiol (1988) 0.80
A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity. J Urol (1998) 0.80
Endothelin in the urinary bladder. II. Characterization of endothelin receptor subtypes. J Urol (1992) 0.79
Combination of phentolamine and L-arginine or sildenafil synergistically improves neurogenic relaxation of rabbit corpus cavernosum smooth muscle. Urology (2001) 0.79
Monoclonal antibodies to human endothelin-1: characterization and utilization in radioimmunoassay and immunocytochemistry. Hybridoma (1992) 0.77
Acidic fibroblast growth factor rescues gerbil hippocampal neurons from ischemic apoptotic death. Neurol Res (1998) 0.77
Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. Clin Sci (Lond) (1997) 0.77
Dysfunctional penile cholinergic nerves in diabetic impotent men. J Urol (1990) 0.76
Nitric oxide as a mediator of relaxation of the corpus cavernosum. N Engl J Med (1992) 0.75
Analgesic effects of fibroblast growth factor in the rat. Neurosci Lett (1996) 0.75
Physicochemical characterization and solubilization of endothelin receptors. Receptor (1991) 0.75
[Erectile dysfunction. An update]. Ugeskr Laeger (1999) 0.75
In vivo and in vitro studies on the physiology of penile erection. Semin Urol (1986) 0.75
Culture of human corpus cavernosum endothelium. In Vitro Cell Dev Biol (1989) 0.75
Functional and radiologic evidence of vascular communication between the spongiosal and cavernosal compartments of the penis. Urology (1997) 0.75
Relative roles of cyclooxygenase and nitric oxide synthase pathways in ischemia-induced increased contraction of cavernosal smooth muscle. J Urol (1999) 0.75